Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cassava Sciences
Biotech
2025's top 10 clinical trial flops
Fierce Biotech looks back at 10 of the most impactful and interesting clinical failures of 2025.
James Waldron
,
Nick Paul Taylor
Feb 9, 2026 3:00am
Altos ascends with new clinical leader—Chutes & Ladders
Aug 8, 2025 8:30am
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Apr 25, 2025 8:30am
Cassava stops Alzheimer's program as simufilam fails again
Mar 25, 2025 9:12am
2024's top 10 clinical trial flops
Feb 18, 2025 3:00am
Cassava cuts 3rd of staff in wake of phase 3 Alzheimer's fail
Jan 8, 2025 3:38am